logo
Select company
Select metric
1.96Cash Ratio
VS
Market
81
Sector
62
Industry
50
History
4
$ 51.36Close
$ 10.8 - $ 80.04 52-Week Range
Ticker Information

Ticker

KRRO

Company Name

KORRO BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KORRO BIO INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KRRO - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 33.61M1.96$ 17.17M
3/31/2025$ 64.14M4.98$ 12.88M
12/31/2024$ 55.64M3.72$ 14.96M
9/30/2024$ 64.97M4.77$ 13.61M
6/30/2024$ 92.92M7.54$ 12.32M
3/31/2024$ 142.35M12.88$ 11.05M
12/31/2023$ 169.71M8.71$ 19.48M
9/30/2023$ 43.69M4.55$ 9.61M
6/30/2023$ 41.67M5$ 8.33M
3/31/2023$ 42.55M1.93$ 22.04M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KORRO BIO INC's latest trailing twelve months (TTM) Cash Ratio stands at 6.87.
  • Over the past 5 years, KORRO BIO INC's average Cash Ratio has been 6.26.
  • The median Cash Ratio for KORRO BIO INC during this period was 4.99
  • KORRO BIO INC reached its highest Cash Ratio over the past 5 years at 15.15.
  • The lowest Cash Ratio recorded by KORRO BIO INC in the same timeframe 1.93

KORRO BIO INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
CRBU : CARIBOU BIOSCIENCES INC 0.87ACOG : ALPHA COGNITION INC 12.98TCRX : TSCAN THERAPEUTICS INC 5.57TVRD : TVARDI THERAPEUTICS INC 1.93OBIO : ORCHESTRA BIOMED HOLDINGS INC 1.1FATE : FATE THERAPEUTICS INC 1.8CRVO : CERVOMED INC 1.79OVID : OVID THERAPEUTICS INC 3.4CBUS : CIBUS INC 1.63ARMP : ARMATA PHARMACEUTICALS INC 0.08

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for KORRO BIO INC is calculated as follows: CashnEq [ $ 226.05M ] / LiabilitesC [ $ 32.92M ]
(=) Cash Ratio [ 6.87 ]

KRRO - Cash Ratio, Last 5 years

1.93

Minimum

Mar 31, 2023

15.15

Maximum

Jun 30, 2021

6.26

Average

4.99

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63